Dr. Eric Vick is a physician-scientist and instructor at the University of Cincinnati focused on novel translational therapies for myeloid neoplasia. He is originally from Nashville, Tennessee. Dr. Vick obtained his B.S. in Biological Sciences in 2009 from the University of Tennessee, and then his Ph.D. in Molecular Biosciences in 2014. He then earned his M.D. from the University of Tennessee Health Science Center in 2018 after which he matched into the Physician-Scientist Training Program at the University of Cincinnati, combining his residency, fellowship, and a dedicated post-doctoral fellowship. He graduated his clinical training in Hematology and Oncology in 2023. Since 2022 Dr. Vick has been working in the Starczynowski Lab, where his project focuses on modalities to combine inflammatory modulation through inhibition of IRAK4 with other small molecule inhibitors. He also studies changes in cancer cells following treatment failure with conventional therapies.